Yoshizawa Naohiko, Yamada Reiko, Sakuno Takashi, Inoue Hiroyuki, Miura Hiroshi, Takeuchi Toshifumi, Nakamura Misaki, Hamada Yasuhiko, Katsurahara Masaki, Tanaka Kyosuke, Horiki Noriyuki, Takei Yoshiyuki
Department of Gastroenterology and Hepatology, Mie University Hospital Department of Endoscopy, Mie University Hospital, Tsu, Mie, Japan.
Medicine (Baltimore). 2018 Jun;97(24):e11096. doi: 10.1097/MD.0000000000011096.
We compared the sample volume of endoscopic ultrasound-guided fine-needle aspiration and biopsy (EUS-FNAB) specimens obtained by 22-gauge (22G) and 25-gauge (25G) needles, and the accuracy rate.This was a retrospective study in a single tertiary referral center. We investigated 153 patients with pancreatic ductal adenocarcinoma (PDAC) who underwent diagnostic EUS-FNAB before neoadjuvant gemcitabine-based chemoradiotherapy between October 2006 and November 2015. We performed immunohistochemical (IHC) analysis of human equilibrative nucleoside transporter 1 using the remnant cell blocks following pathological PDAC diagnosis. We compared the sampling rate, accuracy rate, and success rate of IHC analysis between 22G and 25G.There were 70 patients in the 22G group and 83 patients in the 25G group. The overall sampling rates on cytology and histology were 100% and 98.0%, respectively. The sampling rate did not differ between the 22G and 25G groups. The overall diagnostic accuracy rates on cytology and histology were 94.8% and 79.7%, respectively. The accuracy rates of 22G and 25G groups on cytology were 94.3% and 95.2%, respectively, whereas those on histology were 80.0% and 79.5%, respectively. The diagnostic accuracy on cytology and histology did not differ significantly between the 22G and 25G groups. Of 153 histology specimens, 69.3% of those with PDAC provided sufficient samples for IHC analysis. The success rate of IHC analysis did not differ significantly between the 22G (67.1%) and 25G (71.1%) groups (P = .60).Both 22G and 25G provided a high diagnostic yield with equivalent accuracy rates on histology. EUS-FNAB specimens obtained using 22G or 25G can be equally adequate for IHC analysis and may be suitable for diagnostic examination. Further investigations such as EUS-FNAB needle design and novel cell block preparation are needed to obtain adequate samples for use in "precision medicine."
我们比较了使用22号(22G)和25号(25G)针获取的内镜超声引导下细针穿刺抽吸和活检(EUS-FNAB)标本的样本量及准确率。这是一项在单一三级转诊中心进行的回顾性研究。我们调查了2006年10月至2015年11月期间153例在新辅助吉西他滨为基础的放化疗前接受诊断性EUS-FNAB的胰腺导管腺癌(PDAC)患者。在病理诊断为PDAC后,我们使用剩余细胞块对人平衡核苷转运体1进行免疫组织化学(IHC)分析。我们比较了22G和25G之间的采样率、准确率及IHC分析的成功率。22G组有70例患者,25G组有83例患者。细胞学和组织学的总体采样率分别为100%和98.0%。22G组和25G组的采样率无差异。细胞学和组织学的总体诊断准确率分别为94.8%和79.7%。22G组和25G组细胞学的准确率分别为94.3%和95.2%,而组织学的准确率分别为80.0%和79.5%。22G组和25G组在细胞学和组织学上的诊断准确率无显著差异。在153份组织学标本中,69.3%的PDAC标本为IHC分析提供了足够的样本。22G组(67.1%)和25G组(71.1%)IHC分析的成功率无显著差异(P = 0.60)。22G和25G在组织学上均具有高诊断率且准确率相当。使用22G或25G获取的EUS-FNAB标本在IHC分析中同样适用,可能适合诊断检查。需要进一步研究,如EUS-FNAB针的设计和新型细胞块制备,以获取足够的样本用于“精准医学”。